Please assess the completion status of the following clinical trial:

Trial Title: Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age ≥ 18 years.~2. ECOG performance status 0-1.~3. Known histologically proven malignancy.~4. Localized osteolytic spine metastases from T7 to L5 demonstrated by MRI, CT, PET or bone scan: a solitary spine metastasis; two separate spine levels; or up to 3 separate sites (each site may have a maximal involvement of 2 contiguous vertebral bodies with or without a paraspinal mass of no more than 5 cm).~5. Negative serum pregnancy test within 2 weeks prior to registration for women of childbearing potential.~6. Women of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control.~7. Numerical Rating Pain Scale (NRPS) and movement-related pain score(MRPS) within two (2) weeks prior to registration.~8. The patient must have a score of ≥ 5 for at least one of the planned sites for SRT.~9. Patients must provide study specific informed consent prior to study entry.~10. Required Pre-treatment Evaluations: baseline Numerical Rating Pain Scale (NRPS), movement-related pain score, dose and frequency of all pain medications; QOL Measure using the Oswestry Disability Questionnaire, and EuroQOL(EQ-5D).~Exclusion Criteria:~1. Non-ambulatory patients.~2. Frank spinal cord compression or epidural compression within 3 mm of the spinal cord.~3. Osteoblastic vertebral metastasis.~4. Prior radiation to the index spine.~5. Patients with rapid neurologic decline.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control Group (Type: ACTIVE_COMPARATOR): Baseline Assessments and followup assessments are the same for both arms. Control group Intervention: Stereotactic Radiation Therapy only
- Treatment Group (Type: EXPERIMENTAL): SRT with Vertebral Augmentation Procedure Baseline Assessments and followup assessments are the same for both arms. Treatment group Intervention: Stereotactic Radiation Therapy with Vertebral Augmentation Procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).